Read by QxMD icon Read

Journal of Supportive Oncology

Jamie Hayden Von Roenn
No abstract text is available yet for this article.
December 2013: Journal of Supportive Oncology
Kimberly Lastinger
No abstract text is available yet for this article.
December 2013: Journal of Supportive Oncology
Neil C Estabrook, Stephen T Lutz, Cynthia S Johnson, Mark A Henderson
BACKGROUND: Patients with brain metastases from solid tumors can be subdivided by characteristics into separate prognostic groups, such as the Radiation Therapy Oncology Group's Recursive Partitioning Analysis (RPA) or the Graded Prognostic Assessment (GPA). At our institution, patients falling into the poorest prognostic groups are often treated with whole brain radiotherapy (WBRT). OBJECTIVE: To determine if observed survival of poor prognosis patients treated with WBRT for brain metastases at our institution matches the survival predicted by RPA and GPA prognostic indices...
December 2013: Journal of Supportive Oncology
Jennifer S Gewandter, Joanna Walker, Charles E Heckler, Gary R Morrow, Julie L Ryan
BACKGROUND: Skin reactions and pain are commonly reported side effects of radiation therapy (RT). OBJECTIVE: To characterize RT-induced symptoms according to treatment site subgroups and identify skin symptoms that correlate with pain. METHODS: A self-report survey-adapted from the MD Anderson Symptom Inventory and the McGill Pain Questionnaire--assessed RT-induced skin problems, pain, and specific skin symptoms. Wilcoxon Sign Ranked tests compared mean severity or pre- and post-RT pain and skin problems within each RT-site subgroup...
December 2013: Journal of Supportive Oncology
Kimberly M Davis, David Dawson, Scott Kelly, Sara Red, Sofiya Penek, John Lynch, Sean Collins, Barlow Lynch, Michael Porrazzo, Michael Bass, Kathryn L Taylor
BACKGROUND: Routine symptom and health-related quality of life (HRQOL) assessments can engage patients, give provider feedback, and improve doctor/patient communication. OBJECTIVE: We compared the impact of a technology-assisted symptom monitoring system versus usual care on HRQOL and doctor/patient communication in early-stage prostate cancer (PCa) survivors. METHODS: Men (N = 94) were on average 62-years old, mostly African American (AA; 61...
December 2013: Journal of Supportive Oncology
Andrea R Croom, Heidi A Hamann, Siobhan M Kehoe, Elizabeth Paulk, Deborah J Wiebe
BACKGROUND: Patients with late-stage cancer are living longer, making it important to understand factors that contribute to maintaining quality of life (QOL) and completing advanced illness behaviors (eg, advance directives). OBJECTIVE: To examine whether illness perceptions-the cognitive beliefs that patients form about their cancer-may be more important guides to adjustment than clinical characteristics of the cancer. METHODS: In a cross-sectional study, 105 female patients diagnosed with stage III (n = 66) or IV (n = 39) breast (n = 44), gynecological (n = 38), or lung (n = 23) cancer completed self-report measures of illness perceptions, QOL, and advanced illness behaviors...
December 2013: Journal of Supportive Oncology
Sydney M Dy
Oncology quality measurement programs should include measures in key domains of palliative care and supportive oncology. This article describes an approach to quality measurement in these areas including the key steps of defining the quality measurement goal; identifying stakeholders and audiences; defining the population and setting (including potential characteristics of interest, such as specific conditions or disparities); and choosing the domain, target, and steps in the process of care, such as assessment and treatment...
December 2013: Journal of Supportive Oncology
Barbara A Murphy
There are a number of challenges facing head and neck cancer patients who present with metastatic or locally recurrent head and neck cancer; such as, limited treatment options, overall poor prognosis, and high symptom burden secondary to tumor and treatment. Disease and symptom management can be difficult, and requires that the potential benefits versus the adverse effects of systemic therapy be weighed very carefully. Individual patient characteristics including performance status, weight loss, symptom burden, comorbidities, and social supports must be taken into consideration...
December 2013: Journal of Supportive Oncology
Amanda M Weiland, Bridget McCrate Protus, Jason Kimbrel, Phyllis A Grauer, Jennifer Hirsh
BACKGROUND: Symptom management medications are often compounded into topical gel formulations providing an alternative route of administration for hospice and palliative care patients. Though commonly used, transdermal absorption and bioavailability studies of these gel products are lacking. Chlorpromazine was studied because it is FDA approved for treatment of nausea and vomiting and is used off-label for treatment of agitation and delirium. OBJECTIVE: The objective of this study is to determine the transdermal absorption of chlorpromazine PLO gel in healthy adults...
September 2013: Journal of Supportive Oncology
Leila Kozak, Elizabeth Vig, Carol Simons, Evercita Eugenio, William Collinge, Michael Chapko
PURPOSE: To assess the feasibility of using a multimedia program to teach caregivers of Veterans with cancer how to offer basic massage for supportive care at home. METHODS: Feasibility was assessed according to partner availability, compliance with watching training materials and practicing massage regularly, compliance with data collection; perceived study materials burden; clarity of instructional and other study materials. Pre- and post-massage changes in patients' symptom scores were measured using a numerical rate scale...
September 2013: Journal of Supportive Oncology
Kalen Fletcher, Holly G Prigerson, Elizabeth Paulk, Jennifer Temel, Esme Finlay, Lisa Marr, Ruth McCorkle, Lorna Rivera, Francisco Munoz, Paul K Maciejewski
BACKGROUND: Patient understanding of advanced metastatic disease is central to decisions about care near death. Prior studies have focused on gender differences in communication style rather than on illness understanding. OBJECTIVES: : To evaluate gender differences in terminal illness acknowledgement (TIA), understanding that the disease is incurable and the advanced stage of the disease. To evaluate gender differences in patients' reports of discussions of life expectancy with oncology providers and its effect on differences in illness understanding...
September 2013: Journal of Supportive Oncology
Deena Levine, Catherine G Lam, Melody J Cunningham, Stacy Remke, Jody Chrastek, Jeffrey Klick, Robert Macauley, Justin N Baker
Cancer is the leading cause of disease-related death in children and adolescents. Pediatric patients with cancer suffer greatly at the end of life. However, palliative care interventions can reduce suffering and significantly improve the care of these patients and their families. A large percentage of pediatric deaths occur outside of the hospital setting where pediatric palliative resources may not be readily available. Patients in the home setting may be cared for by community hospice programs, which are typically staffed for adult populations...
September 2013: Journal of Supportive Oncology
Tracy L Truant, Antony J Porcino, Brenda C Ross, Margurite E Wong, Carla T Hilario
This systematic review synthesizes knowledge about the use of complementary and alternative medicine (CAM) among advanced cancer patients. EBSCO and Ovid databases were searched using core concepts, including advanced cancer, CAM, integrative medicine, and decision-making. Articles included in the final review were analyzed using narrative synthesis methods, including thematic analysis, concept mapping, and critical reflection on the synthesis process. Results demonstrate that advanced cancer patients who are younger, female, more educated, have longer duration of disease, and have previously used CAM are more likely to use CAM during this stage of illness...
September 2013: Journal of Supportive Oncology
Sarah Schellhorn Mougalian, David S Lessen, Randy L Levine, Georgia Panagopoulos, Jamie H Von Roenn, Robert M Arnold, Susan D Block, Mary K Buss
BACKGROUND: Burnout among physicians can lead to decreased career satisfaction, physical and emotional exhaustion, and increased medical errors. In oncologists, high exposure to fatal illness is associated with burnout. METHODS: The Maslach Burnout Inventory, measuring Emotional Exhaustion (EE), Depersonalization (DP), and Personal Accomplishment (PA), was administered to second-year US oncology fellows. Bivariate and multivariate analyses explored associations between burnout and fellow demographics, attitudes, and educational experiences...
June 2013: Journal of Supportive Oncology
Sandra Sanchez-Reilly, Laura J Morrison, Elise Carey, Rachelle Bernacki, Lynn O'Neill, Jennifer Kapo, Vyjeyanthi S Periyakoil, Jane de Lima Thomas
It is well known that clinicians experience distress and grief in response to their patients' suffering. Oncologists and palliative care specialists are no exception since they commonly experience patient loss and are often affected by unprocessed grief. These emotions can compromise clinicians' personal well-being, since unexamined emotions may lead to burnout, moral distress, compassion fatigue, and poor clinical decisions which adversely affect patient care. One approach to mitigate this harm is self-care, defined as a cadre of activities performed independently by an individual to promote and maintain personal well-being throughout life...
June 2013: Journal of Supportive Oncology
Monica Krishnan, Jennifer S Temel, Alexi A Wright, Rachelle Bernacki, Kathy Selvaggi, Tracy Balboni
Oncologists frequently face the difficult task of estimating prognosis in patients with incurable malignancies. Their prediction of prognosis informs decision-making ranging from recommendations of cancer treatments to hospice enrollment. Unfortunately, physicians' estimates of prognosis are often inaccurate and overly optimistic. Further, physicians often fail to disclose their prognosis estimates, despite patient wishes to the contrary. Several studies have examined patient factors that might improve physicians' prognostic accuracy, including performance status, clinical symptoms and laboratory values...
June 2013: Journal of Supportive Oncology
Brian C Focht, Steven K Clinton, Steven T Devor, Matthew J Garver, Alexander R Lucas, Jennifer M Thomas-Ahner, Elizabeth Grainger
Findings from prior systematic reviews suggest that exercise results in meaningful improvements in many clinically relevant physiologic and quality of life (QOL) outcomes during and following cancer treatment. However, the majority of exercise-cancer studies have focused upon the benefits of aerobic exercise (AE) and knowledge of the efficacy of resistance exercise (RE) alone as a supportive care intervention for cancer patients and survivors remains limited. Consequently, the purpose of this review was to provide the first systematic evaluation of the effects of RE alone upon clinically relevant physiologic and QOL outcomes during and following cancer treatment...
June 2013: Journal of Supportive Oncology
Hannah R Wardill, Joanne M Bowen, Rachel J Gibson
Gastrointestinal mucosal toxicity is extremely common following cytotoxic therapies. The alimentary mucosa is particularly susceptible to injury and dysfunction, leading to many debilitating complications. Despite much research, there is currently no single noninvasive biomarker to detect gut injury. Several biomarkers have been investigated in the context of gastrointestinal diseases, which may prove useful in the oncology arena. Identification of a biomarker that is easy to obtain and measure and that accurately identifies mucosal damage would allow for improved patient diagnosis of toxicities and for personalized treatment regimens...
June 2013: Journal of Supportive Oncology
Donna L Berry
No abstract text is available yet for this article.
June 2013: Journal of Supportive Oncology
Sally E Jensen, Jennifer L Beaumont, Paul B Jacobsen, Amy Abernethy, Karen L Syrjala, David Cella
BACKGROUND: Improved measurement of clinically meaningful symptoms is needed in advanced bladder cancer. OBJECTIVE: This study developed and examined the initial reliability and validity of a new measure of advanced bladder cancer-specific symptoms, the NCCN-FACT Bladder Symptom Index-18 (NFBISI-18), which assesses the symptoms perceived as most important by patients and oncology clinical experts. METHODS: A total of 31 individuals with advanced bladder cancer rated the importance of 28 symptoms...
June 2013: Journal of Supportive Oncology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"